Warren Averett Asset Management, LLC Cytosorbents Corp Transaction History
Warren Averett Asset Management, LLC
- $9.72 Billion
- Q3 2025
A detailed history of Warren Averett Asset Management, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 55,556 shares of CTSO stock, worth $38,889. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,556Holding current value
$38,889% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
16.8MCall Options Held
0Put Options Held
0-
Avenir Corp Washington, DC5.08MShares$3.56 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.2MShares$1.54 Million0.0% of portfolio
-
Skylands Capital, LLC2.13MShares$1.49 Million0.31% of portfolio
-
Neuberger Berman Group LLC New York, NY1.6MShares$1.12 Million0.0% of portfolio
-
Cm Management, LLC1.29MShares$901,6891.12% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $30.5M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...